Cargando…
Clinical course and end-of-life care in patients who have died after allogeneic stem cell transplantation
PURPOSE: Allogeneic stem cell transplantation may cure approximately 50% of patients, however, a significant part of the other half might benefit from a high-quality palliative care medicine at the end of life. Somatic, psychic and spiritual needs of these patients may differ from those of patients...
Autores principales: | Busemann, Christoph, Jülich, Andreas, Buchhold, Britta, Schmidt, Vanessa, Schneidewind, Laila, Pink, Daniel, Schmidt, Christian Andreas, Neumann, Thomas, Krüger, William H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101727/ https://www.ncbi.nlm.nih.gov/pubmed/28551769 http://dx.doi.org/10.1007/s00432-017-2446-y |
Ejemplares similares
-
Significance of BK Polyomavirus in Long-Term Survivors after Adult Allogeneic Stem Cell Transplantation
por: Neumann, Thomas, et al.
Publicado: (2021) -
Significance of men’s health in long-term survivors of allogeneic stem cell transplantation
por: Schneidewind, Laila, et al.
Publicado: (2022) -
Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation
por: Busemann, Christoph, et al.
Publicado: (2012) -
Targeting IL‐11 in the treatment of BK virus‐associated haemorrhagic cystitis—A promising new approach
por: Schneidewind, Laila, et al.
Publicado: (2020) -
Soll die asymptomatische Bakteriurie bei Immunsupprimierten antibiotisch therapiert werden?: Ein Rapid Review
por: Stangl, Fabian P., et al.
Publicado: (2023)